Astellas is to work with UK biotech Adaptimmune Therapeutics to develop allogeneic ‘off-the-shelf’ T-cell therapies for cancer. The Japanese pharma said its wholly-owned subsidiary Universal ...

Astellas' monoclonal antibody Vyloy (zolbetuximab) has secured approval from Japan’s Ministry of Health, Labour, and Welfare (MHLW) in combination with chemotherapy for the treatment of gastric ...

But a novel strategy used by Astellas Pharma Inc., a pharmaceutical company based in Japan, exploits the body’s own molecular trash-disposal system to address problematic proteins. Around 80% of ...

China detains South Korean on suspicion of espionage Worldcategory· October 29, 2024 The U.S. Food and Drug Administration approved Astellas' therapy to treat a type of gastric cancer ...